$NBEV Surges 19% Ahead of Tomorrow’s CBD Specific FDA Report



This sharp spike seen this morning could be partly due to traders being margined out of their positions, as NBEV has been a favorite among short sellers for several months now.

Stocktwits message board activity at 11:11 am, archived

By Deceptitom – Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=64814713

Leave a Reply

%d bloggers like this: